Literature DB >> 8738406

Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.

S L Jensen1, D P Wood, E R Banks, M Veron, I Lascu, J W McRoberts, V M Rangnekar.   

Abstract

Overexpression of the nm23H1 gene has been associated with the suppression of metastasis in several solid tumors. However, in colorectal carcinoma and neuroblastoma, increased levels of nm23 H1 nucleoside diphosphate kinase A (NDPKA) mRNA are associated with tumorigenesis. To determine the role of nm23 H1/NDPKA in the prostate, normal and/or malignant tissue samples from 29 consecutive patients were studied. Levels of nm23 H1/NDPKA mRNA and nm23 H1/NDPKA mRNA protein were determined in tissue from 18 and 27 patients, respectively. In all, 16 of the 18 tumor samples expressed increased levels of nm23 H1/NDPKA mRNA as compared with those measured in normal tissue. The level of nm23 H1/NDPKA mRNA was > 10-fold higher in a metastatic lymph node than in normal prostate tissue. All cancer specimens and areas of prostatic intraepithelial neoplasia showed immunoreactivity with the nm23 H1/NDPKA antibody; however, normal prostatic tissue was unreactive. These findings suggest that overexpression of the nm23 H1/NDPKA gene occurs frequently in adeno-carcinomas of the prostate and may be an early event in prostate cancer tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738406     DOI: 10.1007/bf00182060

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Cancer statistics, 1992.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1992 Jan-Feb       Impact factor: 508.702

2.  Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer.

Authors:  R Hirayama; S Sawai; Y Takagi; Y Mishima; N Kimura; N Shimada; Y Esaki; C Kurashima; M Utsuyama; K Hirokawa
Journal:  J Natl Cancer Inst       Date:  1991-09-04       Impact factor: 13.506

3.  High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification.

Authors:  N Hailat; D R Keim; R F Melhem; X X Zhu; C Eckerskorn; G M Brodeur; C P Reynolds; R C Seeger; F Lottspeich; J R Strahler
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Evidence for a novel gene associated with low tumor metastatic potential.

Authors:  P S Steeg; G Bevilacqua; L Kopper; U P Thorgeirsson; J E Talmadge; L A Liotta; M E Sobel
Journal:  J Natl Cancer Inst       Date:  1988-04-06       Impact factor: 13.506

5.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

Authors:  G Bevilacqua; M E Sobel; L A Liotta; P S Steeg
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

6.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

7.  Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours.

Authors:  M L Lacombe; X Sastre-Garau; I Lascu; A Vonica; V Wallet; J P Thiery; M Véron
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

8.  Identification of a second human nm23 gene, nm23-H2.

Authors:  J A Stahl; A Leone; A M Rosengard; L Porter; C R King; P S Steeg
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

9.  High levels of nm23 expression are related to cell proliferation in human prostate cancer.

Authors:  M Igawa; D B Rukstalis; T Tanabe; G W Chodak
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.

Authors:  N Konishi; S Nakaoka; T Tsuzuki; K Matsumoto; Y Kitahori; Y Hiasa; T Urano; H Shiku
Journal:  Jpn J Cancer Res       Date:  1993-10
View more
  6 in total

1.  Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Authors:  Archana Mukhopadhyay; Kayann Tabanor; Rathnam Chaguturu; Jane V Aldrich
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

Review 2.  The role of NM23 in patients with colorectal cancer: A systematic review and meta-analysis.

Authors:  Wei Han; Jun Ma; Fang Cao; Cong Zhang; Rong Zhu; Yong-Wei Hu; Min-Bin Chen; Hou-Zhong Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

Review 3.  Immunopathological prognostic and predictive factors in prostate cancer.

Authors:  E Sivridis; S Touloupidis; A Giatromanolaki
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

4.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

Review 5.  Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis.

Authors:  Wei Han; Chun-Tao Shi; Fei-Yun Cao; Fang Cao; Min-Bin Chen; Rong-Zhu Lu; Hua-Bing Wang; Min Yu; Da-Wei He; Qing-Hua Wang; Jie-Feng Wang; Xuan-Xuan Xu; Hou-Zhong Ding
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

Review 6.  Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients: A prisma-compliant meta-analysis.

Authors:  Cheng Yuan; Xin-Hua Xu; Lu Xu; Min Sun; Li-Hua Ni; Yang Liu; Feng Ran; Xiao-Long Wang; Zhuo Chen; Kun Zhang; Guang Zeng
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.